BTW
AGN

Boston Trust Walden’s Allergan Inc AGN Stock Holding History

Boston Trust Walden’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-29,357
Closed -$6.24M – 351
2014
Q4 		$6.24M Sell
29,357
-83
-0.3% -$16.5K 0.09% 204
2014
Q3 		$5.25M Sell
29,440
-1,135
-4% -$189K 0.08% 207
2014
Q2 		$5.17M Sell
30,575
-107,048
-78% -$16.7M 0.08% 203
2014
Q1 		$17.1M Buy
+137,623
New +$16.8M 0.25% 150

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boston Trust Walden's AGN Position: Q1 2015 in Review

Boston Trust Walden sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 29,357 shares — an estimated $6.24M sold.

Boston Trust Walden first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $17.1M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Boston Trust Walden reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Boston Trust Walden sold 29,357 Allergan Inc shares in Q1 2015, an estimated $6.24M.
  • Boston Trust Walden first reported a position in Allergan Inc in Q1 2014 and held it in 4 quarters.
  • Boston Trust Walden's Allergan Inc position peaked at $17.1M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Boston Trust Walden's 13F filing for Q1 2015, filed 15 Apr 2015.